Upadacitinib

Upadacitinib (ABT-494) is a selective Janus kinase (JAK) 1 inhibitor, which is being studied for the treatment of several autoimmune disorders in the IC50 of 43 nM.

Price Not Available 25 mg Upadacitinib Supplier Page

Catalog Number	T7503
Alternative Name(s)	ABT-494
Research Area	JAK/STAT signaling\|\|\|Stem Cells\|\|\|Angiogenesis\|\|\|Chromatin/Epigenetic
Molecular Formula	C17H19F3N6O
CAS#	1310726-60-3
Purity	99.93%
SMILES	CC[C@@H]1CN(C[C@@H]1c1cnc2cnc3[nH]ccc3n12)C(=O)NCC(F)(F)F
Size	25 mg
Supplier Page	https://www.targetmol.com/compound/Upadacitinib
Additional Information	https://www.targetmol.com/datasheet/T7503